Register Now - Next Steps Workshop to explore the science, manufacturing & quality components of generics + biosimilars.

Generic Drugs Are The Prescription For Savings

More than 9 out of 10 generic drug prescriptions are filled for $20 or less.

View Infographic
Capitol Hill Briefing

Patient Access to Affordable Medicines: How a Renegotiated NAFTA Could Keep Drug Prices High

Watch Stream
Next Steps: Manufacturing and Quality Workshop

Join AAM and USP in this workshop, which explores the science, manufacturing and quality components of generics and biosimilars.

Register Now
Patients Can See Their Savings

For the first time ever, the Association for Accessible Medicines is releasing savings data for 20 common patient conditions.

Learn More
Preserve Patient Access in Trade Agreements

Extending monopolies for brand-name drugs in trade agreements only increases patient drug prices. How? The new NAFTA deal decreases drug price competition.

Learn More
Skyrocketing Drug Prices Are a Threat to Everyone

Use this infographic to learn how generics and biosimilars are a remedy to sky-high health care costs.

Read Blog

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Society

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Sep 20, 2018 | Rachel Schwartz

AAM Statement on CBO CREATES Score

Ariel Leaty, cancer patient, generic drug savings

Sep 20, 2018 | Erica Klinger

Generic Prescriptions Save Lives… and Money, Too

Video

Sep 19, 2018 | Erica Klinger

Generic Drugs Are the Prescription for Savings. Don't Take Them for Granted.

FDA's Competitive Generic Therapy (CGT) Designation

Sep 19, 2018 | Erica Klinger

10 Takeaways from the Savings Report

Sep 17, 2018 | Erica Klinger

How a Renegotiated NAFTA Could Keep Drug Prices High for Patients

AAM President & CEO Chester "Chip" Davis, Jr. delivers the State of the Industry Address

Sep 13, 2018 | Rachel Schwartz

Recap: Highlights From the First GRx+Biosims Conference